Clinical Trial Update: Coroflex ISAR 2000 Registry

View source ↗

Summary

Clinical trial update on the Coroflex ISAR 2000 Registry for coronary artery disease sponsored by B. Braun Melsungen, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Coroflex ISAR 2000

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Coronary Artery Disease (CAD) | Status: COMPLETED